Ozempic, a Type 2 diabetes medication, and its sister drug Wegovy, which is specifically approved for weight loss, both contain semaglutide, which mimics GLP-1
B., Meisingset, T
10.1038/244458a0 103 Seveljevic-JaranD.CuzicS.Dominis-KramaricM.GlojnaricI.IveticV.RadosevicS.et al (2006)
Insurers typically require documentation of inadequate glycemic control despite metformin therapy, contraindications to other agents, or presence of specific comorbidities that make GLP-1 therapy medically necessary
Ultimately, 1 article was included in this narrative review
Tirzepatide can help people with type 2 diabetes, obesity, or excessive body fat lose weight and manage their blood sugar levels